User contributions for EProba
29 October 2024
- 10:3810:38, 29 October 2024 diff hist +10 N Fortin, A Created page with "{{Author}}" current
- 10:3710:37, 29 October 2024 diff hist +10 N Wang, C Created page with "{{Author}}" current
- 10:3610:36, 29 October 2024 diff hist +10 N Trudel, M Created page with "{{Author}}" current
- 10:3610:36, 29 October 2024 diff hist +10 N Côté, M Created page with "{{Author}}" current
- 10:3210:32, 29 October 2024 diff hist +10 N Kornyeyeva, E Created page with "{{Author}}" current
- 10:3210:32, 29 October 2024 diff hist +10 N Sun, W Created page with "{{Author}}" current
- 10:3210:32, 29 October 2024 diff hist +10 N Sanchez, R Created page with "{{Author}}" current
- 10:3110:31, 29 October 2024 diff hist +10 N Rossetti, S Created page with "{{Author}}" current
- 10:3110:31, 29 October 2024 diff hist +10 N Lux, EA Created page with "{{Author}}" current
- 10:3110:31, 29 October 2024 diff hist +10 N Lichtman, AH Created page with "{{Author}}" current
- 10:3010:30, 29 October 2024 diff hist −3 Publication: Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain No edit summary current
- 10:2910:29, 29 October 2024 diff hist +10 N Wright, S Created page with "{{Author}}" current
- 10:2910:29, 29 October 2024 diff hist +10 N McQuade, R Created page with "{{Author}}" current
- 10:2810:28, 29 October 2024 diff hist +10 N Weinstein, S Created page with "{{Author}}" current
- 10:2810:28, 29 October 2024 diff hist +10 N Shaiova, L Created page with "{{Author}}" current
- 10:2810:28, 29 October 2024 diff hist +10 N Yanagihara, R Created page with "{{Author}}" current
- 10:2810:28, 29 October 2024 diff hist +10 N Allende, S Created page with "{{Author}}" current
- 10:2710:27, 29 October 2024 diff hist +10 N Portenoy, K Created page with "{{Author}}" current
- 10:2610:26, 29 October 2024 diff hist −2 Publication: Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary current
- 10:2410:24, 29 October 2024 diff hist +10 N Fallon, MT Created page with "{{Author}}" current
- 10:2310:23, 29 October 2024 diff hist +10 N Potts, R Created page with "{{Author}}" current
- 10:2310:23, 29 October 2024 diff hist +10 N Ganae-Motan, ED Created page with "{{Author}}" current
- 10:2210:22, 29 October 2024 diff hist +10 N Lossignol, D Created page with "{{Author}}" current
- 10:2110:21, 29 October 2024 diff hist +10 N Burnell-Nugent, M Created page with "{{Author}}" current
- 10:2110:21, 29 October 2024 diff hist +10 N Johnson, JR Created page with "{{Author}}" current
- 10:2110:21, 29 October 2024 diff hist −3 Publication: Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain No edit summary current
28 October 2024
- 20:4220:42, 28 October 2024 diff hist +84 Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) No edit summary
- 20:2920:29, 28 October 2024 diff hist −3 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 20:2720:27, 28 October 2024 diff hist +73 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 20:1620:16, 28 October 2024 diff hist +1 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 14:0314:03, 28 October 2024 diff hist +66 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 13:5213:52, 28 October 2024 diff hist +398 Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 13:5113:51, 28 October 2024 diff hist +5 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 13:3613:36, 28 October 2024 diff hist +393 Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies No edit summary
- 13:2713:27, 28 October 2024 diff hist +91 Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study No edit summary
- 13:0713:07, 28 October 2024 diff hist 0 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
26 October 2024
- 11:5411:54, 26 October 2024 diff hist +41 Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary
- 11:3911:39, 26 October 2024 diff hist +9 Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary
- 11:2011:20, 26 October 2024 diff hist −178 Publication: Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial No edit summary
- 11:0711:07, 26 October 2024 diff hist +627 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
- 11:0011:00, 26 October 2024 diff hist −756 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
- 10:5210:52, 26 October 2024 diff hist +77 Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial No edit summary
- 10:3410:34, 26 October 2024 diff hist +3 Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain No edit summary
- 10:3210:32, 26 October 2024 diff hist +25 Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain No edit summary
- 10:1810:18, 26 October 2024 diff hist 0 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
- 10:1510:15, 26 October 2024 diff hist +8 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
- 10:0510:05, 26 October 2024 diff hist +6 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
- 10:0010:00, 26 October 2024 diff hist +3 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
- 09:5809:58, 26 October 2024 diff hist −7 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary
- 09:5809:58, 26 October 2024 diff hist +64 Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial No edit summary